老年人中维生素B12缺乏及其与老年综合征的关联
Andria Papazachariou1, Ioanna Papakitsou, Vironas Malikides
1Metabolic Diseases Research Unit, Internal Medicine Laboratory, School of Medicine, University of Crete, Voutes, Greece.
Current opinion in clinical nutrition and metabolic care
|October 23, 2025
概括
维生素B12缺乏症在老年人中很常见,并与认知能力下降和虚弱有关. 早期查和补充可以改善结果,并保持老年人的独立性.
科学领域:
- 老年病的医生 老年病的医生
- 营养神经科学 营养神经科学
- 内部医学 内部医学
背景情况:
- 维生素B12缺乏在老年人中很普遍,并且经常被忽视.
- 老龄化人口面临越来越多的老年综合征,如认知障碍,虚弱和跌倒.
- 这些综合征对老年人造成重大健康负担.
研究的目的:
- 审查证据,将维生素B12缺乏与与年龄相关的临床结果联系起来.
- 为老年人中维生素B12缺乏症的早期发现和管理策略提供指导.
- 综合当前关于B12缺乏及其对老年综合征的影响的研究.
主要方法:
- 这是一个叙事综述,综合了现有的科学文献.
- 该审查侧重于研究维生素B12缺乏和老年综合征的研究.
- 分析了流行病学,病理生理学和临床影响的证据.
主要成果:
- 维生素B12缺乏与神经退行性和神经肌肉变化有关.
- 低B12水平与认知能力下降,抑郁,平衡问题,步态障碍,肉眼和虚弱相关.
- 补充剂有望改善认知和身体功能,特别是在早期.
结论:
- 维生素B12缺乏会显著影响关键的老年综合征.
- 建议在高风险的老年人中进行B12缺乏的常规查.
- 早期干预可以减缓老年综合征的进展,并保持功能独立.
相关概念视频
Vitamins
2.3K
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.3K
Drug Dosing: Geriatric Patients
222
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
222
Pharmacodynamics in Geriatric Patients: Effects of Age
185
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
185
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
195
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
195
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
224
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
224
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
233
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
233


